Results 141 to 150 of about 4,505 (178)

Saxagliptin, Alogliptin, and Cardiovascular Outcomes

New England Journal of Medicine, 2014
Benjamin M, Scirica, Eugene, Braunwald, Deepak L, Bhatt   +2 more
openaire   +5 more sources

Saxagliptin efficacy

Diabetes, Obesity and Metabolism, 2010
openaire   +1 more source

Effect of Saxagliptin on Renal Outcomes in the SAVOR-TIMI 53 Trial

Diabetes Care, 2017
, Eugene Braunwald, Ofri Mosenzon
exaly  

Atropine/epinephrine/saxagliptin

Reactions Weekly, 2023
openaire   +1 more source

Frequency of cancer events with saxagliptin in the SAVOR‐TIMI 53 trial

Diabetes, Obesity and Metabolism, 2016
Lawrence Leiter, Kiho Im, Hwee Teoh
exaly  

Saxagliptin/metformin

Reactions Weekly, 2018
openaire   +1 more source

Dual Add-on Therapy in Type 2 Diabetes Poorly Controlled With Metformin Monotherapy: A Randomized Double-Blind Trial of Saxagliptin Plus Dapagliflozin Addition Versus Single Addition of Saxagliptin or Dapagliflozin to Metformin

Diabetes Care, 2015
Julio Rosenstock, Lars Hansen, Iqbal Nayyar   +2 more
exaly  

Efficacy and safety of saxagliptin in older patients with type 2 diabetes mellitus

Current Medical Research and Opinion, 2011
Julio Rosenstock, Pierre Maheux
exaly  

Saxagliptin/sitagliptin

Reactions Weekly, 2013
openaire   +1 more source

Bioequivalence of Saxagliptin/Metformin Extended-Release (XR) Fixed-Dose Combination Tablets and Single-Component Saxagliptin and Metformin XR Tablets in Healthy Adult Subjects

Clinical Drug Investigation, 2012
David Boulton
exaly